Year of Publication Titlesort descending Faculty Association
2011 Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons. Roberta Diaz Brinton, Ph.D
2010 Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Roberta Diaz Brinton, Ph.D
2012 Minireview: translational animal models of human menopause: challenges and emerging opportunities. Roberta Diaz Brinton, Ph.D
2009 Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2015 Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. Yeon Sun Lee, Frank Porreca, PhD
2003 Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. George Watts, Ph.D.
2016 Neuroendocrinology: Oestrogen therapy affects brain structure but not function. Roberta Diaz Brinton, Ph.D
2014 Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Yeon Sun Lee, Frank Porreca, PhD
2011 Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2013 Neurosteroids as regenerative agents in the brain: therapeutic implications. Roberta Diaz Brinton, Ph.D
2009 Novel bifunctional peptides as opioid agonists and NK-1 antagonists. Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD
2008 Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. Victor Hruby, Ph.D., Yeon Sun Lee, Todd Vanderah, PhD
2017 Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. John M. Streicher, PhD
2011 Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2017 Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. Patrick T Ronaldson, PhD
2009 Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. Jeffrey J. Lochhead, PhD
2017 Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. Roberta Diaz Brinton, Ph.D
2015 Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. Patrick W Mantyh
2012 Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid. Roberta Diaz Brinton, Ph.D
2013 Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. Roberta Diaz Brinton, Ph.D
2010 Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD
2008 Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2004 Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. George Watts, Ph.D.
2015 Perimenopause as a neurological transition state. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.